エイズ時代の結核による死亡の傾向
M M Braun1, T R Coté, C S Rabkin
1Environmental Studies Section, National Cancer Institute, Bethesda, Md.
JAMA
|June 9, 1993
まとめ
既得免疫不全症候群 (AIDS) の流行は,1990年までに米国における若年 (20-49歳) の結核による死亡率を大幅に増加させた. エイズ発生率が高い州では,この年齢層で結核による死亡率が最も増加しました.
科学分野:
- エピデミオロジー エピデミオロジー
- 公衆衛生は公衆衛生である.
- 感染症 感染症は感染症です.
背景:
- 既得免疫不全症候群 (AIDS) の流行は1980年代初頭に発生し,公衆衛生に深刻な影響を及ぼしました.
- 結核 (TB) は歴史的に死亡の重要な原因であり,時間とともに変化するパターンが観察されています.
研究 の 目的:
- 米国における結核死亡率の最近の動向を分析する.
- 具体的には,エイズ流行が結核による死亡,特に若年成人集団における死亡に及ぼす影響を調査する.
主な方法:
- 1980年から1990年にかけての死亡率データを利用した国立保健統計センター.
- 根底にある原因または関連原因として結核および/またはエイズによる死亡を分析した.
- 結核の死亡率を比較するために,AIDSの発生率 (高,中,低) により分類された州.
主要な成果:
- 結核による死亡のバイモダルの年齢分布が明らかになり,エイズ流行と一致する20~49歳の成人の新たなピークが発生した.
- 1990年,20歳から49歳までの年齢層における結核による死亡の54%以上が,エイズ患者であった.
- 結核による死亡は,若い成人の間で,特にエイズの発生率が高い州で (362%の上昇) 顕著に増加しました.
結論:
- エイズ流行は1990年まで,若年成人における結核の死亡率を大幅に増加させた.
- この研究は,結核とエイズの複雑な相互作用を強調し,統合された予防と治療の努力を必要としています.
- AIDSの文脈で結核による死亡と結核による死亡を区別するためにさらなる研究が必要です.
さらに関連する動画
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
関連する概念動画
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
